about
sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In VivoBiomaterial constructs for delivery of multiple therapeutic genes: a spatiotemporal evaluation of efficacy using molecular beacons.Biomaterial-mediated modification of the local inflammatory environment.Variability in Endogenous Perfusion Recovery of Immunocompromised Mouse Models of Limb Ischemia.Co-transfection of decorin and interleukin-10 modulates pro-fibrotic extracellular matrix gene expression in human tenocyte cultureMatrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration.Collagen: finding a solution for the source.A collagen-based scaffold delivering exogenous microrna-29B to modulate extracellular matrix remodelingDrug-eluting biodegradable ureteral stent: New approach for urothelial tumors of upper urinary tract cancer.A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cells.Transfection of macrophages by collagen hollow spheres loaded with polyplexes: a step towards modulating inflammation.A protective extracellular matrix-based gene delivery reservoir fabricated by electrostatic charge manipulation.The neurotoxicity of gene vectors and its amelioration by packaging with collagen hollow spheres.Modulation of inflammation and angiogenesis and changes in ECM GAG-activity via dual delivery of nucleic acids.TGF-β1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels.Multivalent conjugates of basic fibroblast growth factor enhance in vitro proliferation and migration of endothelial cellsEngineered systems for therapeutic angiogenesisA combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesisMatrix-assisted cell transplantation for tissue vascularization
P50
Q28552652-8C830864-0A90-4200-906F-8CB74443B5CDQ34766733-D9F0EDA8-3A37-40DD-A5EB-32AB13C9B6EFQ35609496-547EDB58-1347-4BE9-B723-F5AAA5C2844EQ35910344-8A764DC1-436B-403A-9262-804E101B24E5Q36565065-A108D98A-AA91-4AE4-ADDE-E9CE166250FAQ36852193-04411865-E72C-4E73-B6BB-53B08DFBE671Q36880083-C2715E5C-7EA9-41F1-9BD3-9954FC8BDBABQ37698445-BE2CB1A6-A79F-4227-AEA1-E1BB90DF49E2Q38738554-8E2983C0-FC34-45AB-9DCC-9AEA54A45099Q39027638-9E5AB8EE-7E16-4657-8C8A-ADDC27E4E49DQ39330083-39708B3D-F0D9-4607-B8AE-2D9C38B0086AQ42830247-3B0AC37D-7963-4EC6-BD30-237EE8ADFFEDQ43548541-8CB2E103-18ED-4E44-9599-F1E0E792967CQ45878647-24B6CB39-25DC-430E-8742-3B9CEEB11876Q55382872-000C94B7-6FA1-4937-9C72-2FBF0DBBBC4AQ88212795-CA735DAF-EE95-40B2-8979-1C8DA6A2A303Q88771435-4979C90F-22D5-450A-BBBA-C25A48057F78Q90739896-020A9DC5-00F5-4608-930F-BD72BDD386E9Q90865566-58DE294C-A396-4496-9D4E-89F940C879DD
P50
description
researcher ORCID ID = 0000-0002-1005-1712
@en
wetenschapper
@nl
name
Shane Browne
@ast
Shane Browne
@en
Shane Browne
@es
Shane Browne
@nl
type
label
Shane Browne
@ast
Shane Browne
@en
Shane Browne
@es
Shane Browne
@nl
prefLabel
Shane Browne
@ast
Shane Browne
@en
Shane Browne
@es
Shane Browne
@nl
P106
P31
P496
0000-0002-1005-1712